
Pfizer submits vitiligo data for oral drug approval
Pfizer submits oral drug Litfulo data for nonsegmental vitiligo approval, a condition affecting about 70 million people worldwide.

AI Could Help Social Care But Won’t Replace Human Judgment
AI could improve social care by connecting fragmented systems and flagging risks, but it will not replace the human elements…

Instacart and Unite Us partner on food benefits
Instacart and Unite Us partner on food benefits to simplify rollout of food-as-medicine initiatives for providers nationwide with grocery benefits.

FDA clears DreaMed’s CGM-based insulin dosing tool
FDA clears DreaMed’s MODI system, the first CGM-based tool for automated insulin dosing in Type 2 diabetes patients using multiple…

Patients Use AI Assistants to Record Doctor Visits
Patients use AI assistants to record doctor visits and reconstruct conversations for better follow-up care.

Startup raises $22M to expand at-home HPV screening
Teal Health raises $22M to expand its FDA-authorized at-home HPV screening device, offering self-collection and telehealth follow-up for cervical cancer…

Vance-led crackdown removes 750,000 from ACA plans
Vance-led crackdown removes 750,000 from ACA plans, saving $2.2 billion by canceling subsidies and investigating eligibility.

Hispanic adults now die more from heart disease than cancer
Heart disease now kills more Hispanic adults in the U.S. than cancer, per 2022 data, challenging the 'Hispanic paradox' and…

IL-17 Inhibitors Show Low IBD Risk in HS Patients
IL-17 inhibitors show low IBD risk in HS patients, according to a recent review in JAMA Dermatology.

Oncologists Adopt AI Potential, But Few Use Predictive Models
Oncologists recognize AI's potential to enhance cancer care, yet only 19% utilize predictive models, revealing a significant implementation gap.
